Abstract:Cholesterol is a major component of plasma membranes and unsurprisingly plays a significant role in actively regulating the functioning of several membrane proteins in humans. Notably, recent studies have shown that cholesterol depletion can also impact transmission of potentially painful signals in the context of peripheral inflammation, via hyperexcitability of the voltage-gated sodium channel (Na ) subtype 1.9, but the structural mechanisms underlying this regulation remain to be elucidated. In this study, we focus on the role of cholesterol depletion on Na 1.7, which is primarily expressed in the peripheral sensory neurons and linked to various chronic inherited pain syndromes. Coarse-grained molecular dynamics simulations shed light on the dynamic changes of the geometry of Na 1.7 upon membrane cholesterol depletion: A loss of rigidity at key structural motifs linked to activation and fast-inactivation is observed, as well as changes in the geometry of drug-binding regions in the channel. Loss of rigidity in cholesterol depleted conditions should allow the channel to transition between different gating states more easily. whole-cell patch clamp experiments on HEK293t cells expressing Na 1.7 validated these predictions made at the functional level. Hyperpolarizing shifts in the voltage-dependence of activation and fast-inactivation were observed along with an acceleration of the time to peak and onset kinetics of fast inactivation. These results underline the critical role of membrane composition, and of cholesterol in particular, in influencing Na 1.7 gating characteristics. Furthermore, our results hint to a key role of the membrane environment in affecting drug effects and in pathophysiological dysregulation, sharpening our approaches for analgesics design.

Cholesterol Dependence of the Conformational Changes in Metabotropic Glutamate Receptor 1

Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor by DEER spectroscopy

Cholesterol-β1 AR interaction versus cholesterol-β2 AR interaction.

Cholesterol‐β1AR Interaction Versus Cholesterol‐β2ar Interaction

Cholesterol in Class C GPCRs: Role, Relevance, and Localization

Cholesterol differentially modulates the activity of opioid and muscarinic receptors via common non-canonical binding site

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

An Allosteric Cholesterol Site in Glycine Receptors Characterized Through Molecular Simulations

Cholesterol-dependent dynamic changes in the conformation of the type 1 cholecystokinin receptor affect ligand binding and G protein coupling

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal Stability to the Serotonin1A Receptor

Cholesterol-Beta(1)Ar Interaction Versus Cholesterol-Beta(2)Ar Interaction

Mapping the Functional Binding Sites of Cholesterol in Β2-Adrenergic Receptor by Long-Time Molecular Dynamics Simulations

Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter

State-dependent binding of cholesterol and an anionic lipid to the muscle-type Torpedo nicotinic acetylcholine receptor

A cholesterol switch controls phospholipid scrambling by G protein-coupled receptors

Plasma membrane cholesterol as a regulator of human and rodent P2X7 receptor activation and sensitization

Investigation of Allosteric Modulation Mechanism of Metabotropic Glutamate Receptor 1 by Molecular Dynamics Simulations, Free Energy and Weak Interaction Analysis

Depletion of membrane cholesterol modifies structure, dynamic and activation of Na 1.7

Exploring the Activation Mechanism of Metabotropic Glutamate Receptor 2

Human class B1 GPCR modulation by plasma membrane lipids